Annis Gardner Whiting Capital Advisors’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
PRS
PWMAG
IA
HNB
Annis Gardner Whiting Capital Advisors's EXAS Position: Q1 2026 in Review
Annis Gardner Whiting Capital Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 7,330 shares — an estimated $744K sold.
Annis Gardner Whiting Capital Advisors first reported a position in EXAS in Q3 2023 and held it in 8 quarters. The position peaked at $877K in Q3 2024. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Annis Gardner Whiting Capital Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Annis Gardner Whiting Capital Advisors sold 7,330 Exact Sciences shares in Q1 2026, an estimated $744K.
- Annis Gardner Whiting Capital Advisors first reported a position in Exact Sciences in Q3 2023 and held it in 8 quarters.
- Annis Gardner Whiting Capital Advisors's Exact Sciences position peaked at $877K in Q3 2024.
- 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q1 2026, filed 6 May 2026.